Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer's disease

Jin Hu1, Qiang Chen1, Hongrui Zhu2

  • 1State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Department of Neuroscience, the First Affiliated Hospital, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China.

Neuron
|November 11, 2022
PubMed

Insights

Alzheimer's disease microglia use Piezo1 channels to sense amyloid-β plaque stiffness, promoting plaque clearance. Blocking Piezo1 worsens Alzheimer's pathology and cognitive decline.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biophysics

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) plaques.
  • The mechanical influence of Aβ plaques on brain tissue and microglial function is poorly understood.
  • Microglial mechanosensing pathways in AD pathogenesis remain largely unexplored.

Purpose of the Study:

  • Investigate the role of microglial mechanosensing in Alzheimer's disease.
  • Determine if mechanical properties of Aβ plaques influence microglial behavior.
  • Identify potential therapeutic targets for AD based on microglial mechanosensing.

Main Methods:

  • Surveyed tissue stiffness in Aβ plaque-associated regions.
  • Observed Piezo1 ion channel expression in microglia near Aβ plaques.
  • Utilized Piezo1 knockout and pharmacological activation in 5×FAD mouse models.
  • Assessed Aβ pathology and cognitive function.

Main Results:

  • Aβ plaque-associated brain tissues exhibit increased stiffness.
  • The mechanosensitive ion channel Piezo1 is upregulated in microglia near Aβ plaques.
  • Piezo1 activation by Aβ fibril stiffness triggers microglial clustering and phagocytosis, compacting plaques.
  • Loss of Piezo1 exacerbates Aβ pathology and cognitive deficits.
  • Pharmacological Piezo1 activation reduces Aβ burden and improves cognition in AD mice.

Conclusions:

  • Microglial Piezo1 acts as a mechanosensor for Aβ fibril stiffness.
  • Piezo1-mediated microglial responses are crucial for mitigating Aβ pathology.
  • Targeting microglial Piezo1 offers a potential therapeutic strategy for Alzheimer's disease.

Related Concept Videos